Investing in Vision: CRO Insights for Ophthalmic Innovators

Ophthalmology Investment Space Webinar with Jeanne Hecht and David Tanzer Header Graphic

In this webinar, Lexitas CEO & Chairwoman, Jeanne Hecht, and CMO, David J. Tanzer, MD, ABO, discuss the ophthalmology investment space and clinical trial trends- including common pitfalls in clinical development, and insights on trial starts for key ophthalmic indications.

Jeanne and David discuss:

– Strategic guidance for investors and sponsors working in the ophthalmic development space

– Ophthalmology market opportunity & investment trends

– Recent innovations in anterior and posterior segment indications

– Ophthalmic clinical trial design & success rates

Watch the Video

Our Visionary Insights newsletter is published once a month and has thousands of subscribers. To stay in touch, subscribe today.